Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



CVS Caremark Corporation Earnings: Will Growth Crush Rival Rite Aid?

On Friday, CVS Caremark (NYSE: CVS  ) will release its quarterly report, and investors have been impressed by the drugstore chain's ability to outpace competitors Walgreen (NASDAQ: WBA  ) and Rite Aid (NYSE: RAD  ) with its past growth in sales and net income. Yet as Rite Aid has recovered and Walgreen attempts to accelerate its growth, CVS Caremark needs to take care not to squander its competitive advantages and continue moving toward dominating the drugstore-retail industry.

CVS has come a long way in a short period of time, having gone beyond its initial simple drugstore business model to incorporate the Caremark pharmacy-benefits management business. Doing so helped create a vertically integrated behemoth with considerable advantages over Rite Aid and Walgreen because of the potential for capturing additional retail business via cross-selling. But CVS Caremark's recent decision to stop selling tobacco has raised concerns about growth going forward. Let's take an early look at what's been happening with CVS Caremark over the past quarter and what we're likely to see in its report.

Source: CVS Caremark.

Stats on CVS Caremark

Analyst EPS Estimate


Change From Year-Ago EPS


Revenue Estimate

$32.31 billion

Change From Year-Ago Revenue


Earnings Beats in Past 4 Quarters


Source: Yahoo! Finance.

Will CVS earnings keep climbing higher this quarter?
In recent months, analysts have had mixed views on CVS earnings, raising their first-quarter estimates by $0.06 per share but cutting their full-year 2015 projections slightly. The stock has kept performing well, though, climbing 8% since late January.

CVS Caremark's fourth-quarter earnings report helped boost investor confidence in the drugstore chain, with profits rising 12% on a 4.6% sales increase from the year-ago quarter. Pharmacy same-store prescription volume rose 3.8%, and cost inflation drove revenue for the segment up 5.2%. CVS also raised its earnings guidance for the first quarter by 5% to 8%, and it foresaw strength throughout 2014 in its financial results.

Source: hattiesburgmemory via Wikimedia Commons.

But drawing much more interest from investors was CVS Caremark's decision to stop selling tobacco products in its stores by this October. Although tobacco is a lucrative product for CVS, the company said that in its efforts to promote health and reduce disease, stopping tobacco sales will make tobacco-related illnesses less common. Some believe that CVS Caremark might be able to benefit from new agreements with health-care providers to provide patient services as a result of the move. So far, Rite Aid, Walgreen, and other prescription providers haven't followed suit, which could give CVS an additional reputational boost as the first mover on the issue.

Still, CVS can't afford to ignore its competitors. Rite Aid has made an impressive comeback, as its most recent earnings came in well above forecasts. Rite Aid enjoyed a 2.1% jump in comps, with pharmacy gains of 3.5% driving the overall growth. Rite Aid still trails CVS by a wide margin in many key business metrics, but Rite Aid's revival from what many thought would be certain failure means that CVS can't afford to concentrate only on Walgreen in considering its future moves. Moreover, with Rite Aid having bought RediClinic to boost its presence in the retail mini-clinic arena, CVS Caremark will face competition in that growing niche as well, especially if Rite Aid's store remodeling efforts bring in more customers.

In the CVS earnings report, watch to see how the company compares to Rite Aid's recent results, both in pharmacy sales and in front-of-store results. Moreover, take a close look at the pharmacy-benefits side of CVS Caremark's business. If PBM goes well, it could provide the growth that could crush Rite Aid's recovery.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion-dollar industry." And the technology behind it is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential and its ability to make life-changing medical solutions never thought possible.  To learn how you can invest in this unbelievable new technology, click here now to see our free report.

Click here to add CVS Caremark to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2938879, ~/Articles/ArticleHandler.aspx, 8/27/2015 5:31:08 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Caplinger

Dan Caplinger has been a contract writer for the Motley Fool since 2006. As the Fool's Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on With a background as an estate-planning attorney and independent financial consultant, Dan's articles are based on more than 20 years of experience from all angles of the financial world.

Today's Market

updated Moments ago Sponsored by:
DOW 16,654.77 369.26 2.27%
S&P 500 1,987.66 47.15 2.43%
NASD 4,812.71 115.17 2.45%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/27/2015 4:02 PM
CVS $105.20 Up +2.33 +2.26%
CVS Health CAPS Rating: ****
RAD $8.24 Up +0.28 +3.52%
Rite Aid Corp CAPS Rating: ***
WBA $87.85 Up +2.44 +2.86%
Walgreen Boots All… CAPS Rating: ****